Park Ha Biological Tech Files 6-K for Sept 2025

Ticker: BYAH · Form: 6-K · Filed: Sep 18, 2025 · CIK: 1986247

Sentiment: neutral

Topics: reporting, foreign-private-issuer, sec-filing

TL;DR

Park Ha Biological Tech (PRKBT) filed a 6-K for Sept 2025, confirming 20-F filing.

AI Summary

Park Ha Biological Technology Co., Ltd. filed a Form 6-K on September 18, 2025, reporting for the month of September 2025. The company, incorporated in F4 and headquartered in Wuxi City, China, is involved in the SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS industry. This filing indicates they will file their annual reports under Form 20-F.

Why It Matters

This filing provides an update on Park Ha Biological Technology Co., Ltd.'s reporting status and confirms their adherence to SEC regulations for foreign private issuers.

Risk Assessment

Risk Level: low — This is a routine filing confirming reporting status and does not contain new financial or operational information.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a report of foreign private issuer for the month of September 2025, indicating the company's ongoing reporting obligations.

Which SEC form does Park Ha Biological Technology Co., Ltd. use for its annual reports?

Park Ha Biological Technology Co., Ltd. indicates it files annual reports under cover of Form 20-F.

Where is Park Ha Biological Technology Co., Ltd. headquartered?

The company's principal executive office is located at 901, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China.

What is the Standard Industrial Classification (SIC) code for Park Ha Biological Technology Co., Ltd.?

The SIC code listed is 2840, which corresponds to SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS.

When was this Form 6-K filed?

This Form 6-K was filed on September 18, 2025.

Filing Stats: 253 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2025-09-18 07:17:45

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ FORM 6-K _______________ REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 _______________ Park Ha Biological Technology Co., Ltd. (Exact name of registrant as specified in its charter) _______________ 901, Building C Phase 2, Wuxi International Life Science Innovation Campus 196 Jinghui East Road Xinwu District, Wuxi, Jiangsu Province People’s Republic of China 214000 (Address of Principal Executive Office) _______________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20 -F or Form 40 -F . Form 20 -F             Form 40 -F   2025 Annual General Meeting In connection with the 2025 annual general meeting of Park Ha Biological Technology Co., Ltd., a Cayman Islands company (the “ Company ”), the Company hereby furnishes the following documents: Exhibits Exhibit No.   Description 99.1   Notice of 2025 Annual General Meeting, dated September 12, 2025, to be mailed to the shareholders of the Company 99.2   Form of Proxy Card to be mailed to the shareholders of the Company 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: September 18, 2025   Park Ha Biological Technology Co., Ltd.     By:   / s / Xiaoqiu Zhang     Name:   Xiaoqiu Zhang     Title:   Chief Executive Officer and Chairperson of the Board 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing